Texas Yale Capital Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Texas Yale Capital Corp's VRTX Position: Q2 2026 in Review
Texas Yale Capital Corp increased its Vertex Pharmaceuticals (VRTX) stake by 1.7% in Q2 2026, buying an estimated $33.2K and bringing the position to 4,419 shares worth $2.2M. The position accounts for 0.05% of the portfolio, ranked #206.
Texas Yale Capital Corp first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Texas Yale Capital Corp held 4,419 shares of Vertex Pharmaceuticals worth $2.2M as of Q2 2026.
- Texas Yale Capital Corp bought 75 Vertex Pharmaceuticals shares in Q2 2026, an estimated $33.2K.
- Vertex Pharmaceuticals made up 0.05% of Texas Yale Capital Corp's portfolio in Q2 2026, its #206 holding.
- Texas Yale Capital Corp first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.